Wikidata

(Q63580901)

English

Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis

clinical trial

In more languages

Statements

title
A Phase 2b Dose-finding Study for SAR442168, a Bruton's Tyrosine Kinase Inhibitor, in Participants With Relapsing Multiple Sclerosis (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
sponsor
Sanofi
0 references
country
Canada
0 references
start time
29 March 2019
0 references
end time
December 2019
0 references
number of participants
120
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63580901&oldid=1857287666"